Implementing post-genomic personalized medicine: The rise of glycan biomarkers

Implementing post-genomic personalized medicine: The rise of glycan biomarkers

Publication date: Jan 14, 2020

Credit: CC0 Public Domain An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology.

This special issue was co-edited by Wei Wang, MD, Ph. D., Edith Cowan University (Joondalup, Australia) and Capital Medical University (Beijing, China), and Vural cD6zdemir, MD, Ph. D., Editor-in-Chief of OMICS: A Journal of Integrative Biology.

Vural cD6zdemir, MD, Ph. D., Editor-in-Chief of OMICS: A Journal of Integrative Biology states: “Carbohydrates and glycans matter for personalized medicine.

This OMICS special issue on glycomics and personalized glycomedicine signals the rise of glyco-theranostics as a new specialty in diagnostic medicine and systems science.

Concepts Keywords
Australia Greater systems
Beijing Move systems
Biomarkers Branches of biology
Cardiovascular Natural sciences
CC0 Carbohydrate chemistry
China Omics
Croatia Carbohydrates
Diabetes Genomics
Domzale Glycomics
Edith Cowan Multiomics
Epigenomics Glycome
Fair Dealing Precision medicine
Genomics Genomics
Glycan Glycomics
Glycans Epigenomics
Glycobiology Transcriptomics
IgG Proteomics
Immunoglobulin Metabolomics
Joondalup
Ljubljana
Medicine
Mellitus
Metabolomics
Omics
OMICS
Personalized Medicine
Precision Medicine
Proteomics
Renal Failure
Slovenia
Systems Science
T2D
Team Australia
Theranostics
Transcriptomics
Wei

Semantics

Type Source Name
disease MESH Type 2 Diabetes Mellitus
disease MESH risk factors
disease MESH diagnosis
disease MESH cardiovascular disease
disease MESH renal failure

Similar

Leave a Comment

Your email address will not be published. Required fields are marked *